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Abstract  
Loss of vision due to eye metastasis is generally uncommon, representing an ophthalmological diagnostic and therapeutic challenge. We here 
report a case of a smoker patient finally diagnosed with lung cancer, whose initial symptom was visual loss due to choroidal metastasis. Given that 
the majority of subjects presenting with uveal metastasis have already developed other distant metastases as well, a complete diagnostic work-up 
of these patients is always required. Despite being rare, eye metastasis from a lung malignancy should always be suspected in smokers presenting 
with progressive vision deterioration. 
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Gradual loss of vision is one of the commonest reasons for which 
patients present to the ophthalmologist. It may have various causes 
which can be divided into two main categories, according to the 
reversibility of the visual loss. Reversible conditions include, among 
others, cataract, refractive error and diabetic macular œdema, while 
irreversible ones are optic atrophy, glaucoma, retinitis pigmentosa 
and age-related macular degeneration [1]. Loss of vision due to eye 
metastasis is generally uncommon, representing an 
ophthalmological diagnostic and therapeutic challenge.  
  
  
Patient and observation 
 
A 60-year-old female patient, with history of smoking habit (80 
packyears), presented with complaints of progressive visual loss 
from her right eye. Her symptoms had started approximately two 
months prior to presentation. Best-corrected visual acuity was 6/24 
in the right eye and 6/5 in the left eye. Anterior segment 
examination was unremarkable in both eyes. Intraocular pressure 
was within normal limits, there was no relative afferent pupillary 
defect and the vitreous was clear in both eyes. Dilated fundus 
examination showed an elevated juxtpapillary yellowish mass in the 
right eye with an associated macular detachment (Figure 1), which 
was confirmed by Optical Coherence Tomography (OCT). The 
differential diagnosis mainly included amelanotic choroidal 
melanoma, circumscribed choroidal hemangioma and choroidal 
metastasis. Fundus Fluorescein Angiography (FFA) (Figure 2, 
Figure 3),Indocyanine Green Angiography (IGA) (Figure 4) and B 
scan were performed and confirmed the presence of choroidal 
metastasis. Subsequently, the patient was referred to the Internal 
Medicine department, where she underwent Computed Tomography 
(CT) scan of the brain, chest and abdomen, bone scan, as well as 
gastroscopy and colonoscopy. The imaging methods revealed a 
lesion located at the upper lobe of the right lung and pathologically 
enlarged local lymph nodes. Moreover, numerous bone metastases 
were detected. The patient was subjected to bronchoscopy and 
histological results from the biopsy taken from the tumor were 
compatible with small cell carcinoma. She died three months later 





Small cell lung cancer (SCLC) is a highly metastatic type of lung 
cancer, which is etiologically directly associated with tobacco use 
[2]. It has been estimated that almost 70% of the patients suffering 
from SCLC are presenting with locally advanced or metastatic 
disease at the time of diagnosis [3], with most frequent sites being 
liver, bones, brain, lungs and adrenal glands [4]. Choroidal 
metastases, the most common malignant intraocular lesions, occur 
mainly in lung and breasts carcinomas [5]. However, rarely, they 
have been reported in other types of cancer. Given that the majority 
of subjects presenting with uveal metastasis have already developed 
other distant metastases as well [6], a complete diagnostic work-up 
of these patients is always required. Unfortunately, overall survival 
time in these cases does not seem to exceed 12 months [6]. 
Methods for the diagnosis and investigation of ocular metastases 
include ultrasonography, fluorescein angiography, computed 
tomography, magnetic resonance imaging (MRI), fine-needle 
aspiration and wedge biopsy. With regard to therapeutic options, 
external beam radiotherapy remains the treatment of choice [5]. 
Bevacizumab, a monoclonal antibody, has been used in the 
treatment of choroidal metastasis and relevant studies have 





In our patient, visual loss was the initial presentation of lung cancer 
and the symptom that finally led to the diagnosis. In conclusion, 
despite being rare, eye metastasis from a lung malignancy should 
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Figure 1: Color funds photograph of the Right Eye (RE) showing a 
yellowish juxtpapillary subretinal mass with associated serous 
macular detachment  
Figure 2: Fundus Fluorescein Angiography (FFA) of the RE, early 
frames, showing hypofluorescence of the mass as a result of 
transmission defect from the choroidal circulation  
Figure 3: FFA of the RE, late frames, showing hyperfluorescence of 
the mass due to dye leakage  
Figure 4: Indocyanine Green Angiography (ICG) of the RE, late 
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Figure 1: Color funds photograph of the Right Eye (RE) showing a 
yellowish juxtpapillary subretinal mass with associated serous 






Figure 2: Fundus Fluorescein Angiography (FFA) of the RE, early 
frames, showing hypofluorescence of the mass as a result of 
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Figure 3: FFA of the RE, late frames, showing hyperfluorescence of the mass 







Figure 4: Indocyanine Green Angiography (ICG) of the RE, late frames. The 
lesion is hypofluorescent throughout the study 
 
 
 
 
 
 
 
